e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases

被引：17
|
作者：
Mondal, B. C.
Majumdar, S.
Dasgupta, U. B.
Chaudhuri, U.
Chakrabarti, P.
Bhattacharyya, S.
机构：
[1] Univ Calcutta, Dept Biophys Mol Biol & Genet, Kolkata 700009, W Bengal, India
[2] Inst Haematol & Transfus Med, Kolkata, W Bengal, India
来源：
JOURNAL OF CLINICAL PATHOLOGY | 2006年 / 59卷 / 10期
关键词：
D O I：
10.1136/jcp.2005.029595
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
This report describes two patients with chronic myeloid leukaemia (CML): one of them developed accelerated phase CML and died 8 years after diagnosis and the other is at the chronic phase. Sequence analysis of reverse transcription-polymerase chain reaction products showed the presence of BCR-ABL fusion transcript e19a2. This finding suggests that CML carrying mu-BCR breakpoint may exhibit a clinical course similar to typical CML.
引用
收藏
页码：1102 / 1103
页数：2
相关论文
共 50 条
  • [21] FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions
    Philippa C. May
    Alistair G. Reid
    Mark E. Robinson
    Jamshid S. Khorashad
    Dragana Milojkovic
    Simone Claudiani
    Fenella Willis
    Jane F. Apperley
    Andrew J. Innes
    BMC Medical Genomics, 16
  • [22] A pharmacodynamic model of Bcr-Abl signalling in chronic myeloid leukaemia
    Jackson, Robert C.
    Radivoyevitch, Tomas
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 765 - 776
  • [23] Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction – is it truly a benign disease?
    GF How
    LT Tan
    LC Lim
    Leukemia, 1998, 12 : 1166 - 1167
  • [24] BCR-ABL peptide immunisation in chronic myeloid leukaemia (CML)
    Clark, RE
    Knight, K
    Wang, L
    Rojas, JM
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 54 - 54
  • [25] Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction - is it truly a benign disease?
    How, GF
    Tan, LT
    Lim, LC
    LEUKEMIA, 1998, 12 (07) : 1166 - 1167
  • [26] Detection of BCR-ABL fusion gene and its transcript variants in chronic myeloid leukaemia patients - a multi-comparison study
    Javed, Ali
    Mukhtar, Hamid
    Kubra, Kadija Tul
    Lodhi, Sidrah
    Abaidullah, Sajid
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2020, 70 (10) : 1757 - 1761
  • [27] e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
    Colla, S
    Sammarelli, G
    Voltolini, S
    Crugnola, M
    Sebastio, P
    Giuliani, N
    HAEMATOLOGICA, 2004, 89 (05) : 611 - 613
  • [28] Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts
    Lee, JJ
    Kim, HJ
    Kim, YJ
    Lee, S
    Hwang, JY
    Kim, YL
    Kim, DW
    LEUKEMIA, 2004, 18 (09) : 1539 - 1540
  • [29] A CASE REPORT WITH E6A2 BCR-ABL FUSION TRANSCRIPT WITH MARKED BASOPHILIA AND HIGH ACTIVATION OF SRC KINASES DOWNSTREAM BCR-ABL
    Divoka, M.
    Rohon, P.
    Calabkova, L.
    Mojzikova, R.
    Novosadova, A.
    Faber, E.
    Jarosova, M.
    Holzerova, M.
    Indrak, K.
    Divoky, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 541 - 541
  • [30] Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts
    J-J Lee
    H-J Kim
    Y-J Kim
    S Lee
    J-Y Hwang
    Y-L Kim
    D-W Kim
    Leukemia, 2004, 18 : 1539 - 1540
12345